>

PARABOLIC DRUGS (India) Valuation

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:4em;padding-top: 25px;;'>PA</div>
PARABOLIC DRUGS recent Real Value cannot be determined due to lack of data. The prevailing price of PARABOLIC DRUGS is 0.0. Based on Macroaxis valuation methodology, the entity cannot be evaluated at this time. This module determines value of PARABOLIC DRUGS from inspecting the entity fundamentals such as Operating Margin of (116.20) , Profit Margin of (133.30)  and Price to Earning of (0.44)  as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point future time stocks prices and their ongoing real values will merge together.
PARABOLIC DRUGS is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to sales category among related companies .
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Your Equity Center. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Company logos by clearbit